scholarly journals OP11.11: Spectrum of disorders of fetal cardiac rate and rhythm in anti‐Rho‐positive mothers: a single centre experience over one year

2019 ◽  
Vol 54 (S1) ◽  
pp. 123-123
Author(s):  
A. Sharma ◽  
V. Dadhwal ◽  
J.J. Chawla
2020 ◽  
Vol 15 (2) ◽  
pp. 156-160 ◽  
Author(s):  
Marcin Sochal ◽  
Monika Krzywdzińska ◽  
Agata Gabryelska ◽  
Renata Talar-Wojnarowska ◽  
Ewa Małecka-Panas

2018 ◽  
Vol 30 (6) ◽  
pp. e64
Author(s):  
J. Ho ◽  
M. O'Cathail ◽  
R. Clements ◽  
K. Foweraker ◽  
M. Griffin ◽  
...  

Pathogens ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 964
Author(s):  
Mariarosaria Campise ◽  
Carlo Maria Alfieri ◽  
Marta Perego ◽  
Francesco Tamborini ◽  
Donata Cresseri ◽  
...  

COVID-19 is a life-threatening infection among elderly patients, comorbid patients, or transplanted patients. Lombardy (region of Italy), accounts for 786,324 cases as of 21 April 2021. We retrospectively describe our single Centre experience in 82 adult kidney-transplant patients with COVID-19 infection during two pandemic outbreaks: 27 (first outbreak) and 65 (second outbreak). Thirty-seven patients were hospitalized (HP) and sixty-five were home managed (HM). Infection presented with fever (80%), cough (51%), and dyspnea (33%). HP were older (60 ± 11 vs. 50 ± 14 years, p = 0.001), had more severe respiratory symptoms (dyspnea 62.1%, p < 0.0001–cough 67% p = 0.008), and a longer length of disease (30 ± 28 vs. 21 ± 10, p = 0.04). The incidence of acute kidney injury (AKI) was 29.7% (p < 0.0001). Steroid dosage was increased in 66% of patients (p = 0.0003), while calcineurin inhibitors were reduced by up to one third in 45% of cases, p < 0.0001. Eleven patients died (13%). HM patients recovered completely without sequelae. In the overall cohort, AKI development (p = 0.006 OR 50.4 CI 95% 3.0–836) and age (p = 0.04 OR 1.1 CI 95% 1.0–1.2) were the most important factors influencing the probability of death during the infection. Although we report a relatively low incidence of infection (5.1%) the incidence of death is almost four times higher than it is in the general population.


Author(s):  
A Mirian ◽  
S McFadden ◽  
P Edmond ◽  
V Bhayana ◽  
L Yang ◽  
...  

Background: We reviewed our autoimmune encephalitis neural antibody testing using brain tissue indirect immunofluorescence (TIIF) and cell-based assays (CBAs) after one year. Methods: Samples were tested from March 2019–March 2020 by TIIF and CBA for anti-NMDAR, LGI1, CASPR2, AMPAR, GABA(B)R, DPPX, IgLON5 and GAD65. Weakly positive or positive CBA, with or without corresponding TIIF positivity, was reported positive. Clinical questionnaires were submitted for clinical-serological correlation. Patients with a compatible clinical phenotype and no more likely alternative diagnosis were classified as true-positives, while all others were flagged as possible false-positives. Results: Twenty of 373 patients (5.4%) had a positive neural antibody. All anti-LGI1 (N=4), GAD65 (N=4), and GABA(B)R (N=1) were classified as true-positives. In contrast, only 3/6 anti-CASPR2 and 3/5 anti-NMDAR were classified as true-positives. Among true-positives, 2/4 anti-LGI and 3/3 anti-CASPR2 were positive by CBA only. All possible false-positive results exhibited only weak serum staining by CBA, with negative serum TIIF and negative CSF CBA/TIIF (if available). Conclusions: Clinical sensitivity of CBA seems higher than TIIF for neural antibodies studied herein, but may come at some expense to clinical specificity. Among patients with weak serum staining by CBA, correlation with serum TIIF, CSF CBA/TIIF, and clinical presentation is recommended.


EP Europace ◽  
2015 ◽  
Vol 18 (7) ◽  
pp. 987-993 ◽  
Author(s):  
Ghazala Irfan ◽  
Carlo de Asmundis ◽  
Giacomo Mugnai ◽  
Jan Poelaert ◽  
Christian Verborgh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document